Current Topics in iPSCs provides a deep analysis of the underlying fundamentals that support short and mid-term developments and milestones in the business of mesenchymal stem cell therapies. This volume explores the next frontier of MSC therapies and how the transformational potential of therapeutic adult cells will be realised in all therapy areas. The impacts of clinical and economic benefits are dissected throughout each of the chapters. Written by thought leaders in the field for those curious about the interface of science and business.
Current Topics in iPSCs provides a deep analysis of the underlying fundamentals that support short and mid-term developments and milestones in the business of mesenchymal stem cell therapies. This volume explores the next frontier of MSC therapies and how the transformational potential of therapeutic adult cells will be realised in all therapy areas. The impacts of clinical and economic benefits are dissected throughout each of the chapters. Written by thought leaders in the field for those curious about the interface of science and business.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
1. Regulatory and Policy Considerations in iPSC Research 2. HiPSCs for Population Genetics 3. Using Human Induced Pluripotent Stem Cells to Advance Personalized/Precision Medicine 4. hiPSC disease modeling with 3D organoids: Bioengineering perspective 5. The Differentiation of Embryonic Stem Cells and Induced Pluripotent Stem Cells into Airway and Alveolar Epithelial Cells 6. Transplantation of iPSC-derived human kidney organoids 7. An update on clinical applications of iPSCs from a genomic point of view 8. DNA Damage and Replication in Induced Pluripotent Stem Cells 9. Epigenetic modifications in induced pluripotent stem cells to boost myogenic commitment 10. Applications for Induced Pluripotent Stem Cells (iPSC) in Reproductive Medicine 11. iPSCs in Insulin Resistance, Type 2 Diabetes and the Metabolic Syndrome 12. Induced pluripotent stem cells for cystic fibrosis 13. Exploring 15q13.3 Copy Number Variants in iPSCs 14. Human induced pluripotent stem cells for modeling Brugada syndrome 15. iPSCs for Erythromycin Arrhythmogenicity Testing 16. Therapeutic Potential of Induced Pluripotent Stem Cell derived Extracellular Vesicles: Quo Vadis? Terra Incognito 17. Proteomic Approach for Creation of the Protein Marker Panels to Control for Quality of Human Induced Pluripotent Stem Cells (hiPSCs) 18. Application of induced pluripotent stem cells in tissue engineering 19. Application of iPSC-derived secretome in regenerative medicine 20. iPSCs and toxicology: predictive tool for present and future 21. Rejuvenation through iPSCs and reprogramming in vivo and in vitro
1. Regulatory and Policy Considerations in iPSC Research 2. HiPSCs for Population Genetics 3. Using Human Induced Pluripotent Stem Cells to Advance Personalized/Precision Medicine 4. hiPSC disease modeling with 3D organoids: Bioengineering perspective 5. The Differentiation of Embryonic Stem Cells and Induced Pluripotent Stem Cells into Airway and Alveolar Epithelial Cells 6. Transplantation of iPSC-derived human kidney organoids 7. An update on clinical applications of iPSCs from a genomic point of view 8. DNA Damage and Replication in Induced Pluripotent Stem Cells 9. Epigenetic modifications in induced pluripotent stem cells to boost myogenic commitment 10. Applications for Induced Pluripotent Stem Cells (iPSC) in Reproductive Medicine 11. iPSCs in Insulin Resistance, Type 2 Diabetes and the Metabolic Syndrome 12. Induced pluripotent stem cells for cystic fibrosis 13. Exploring 15q13.3 Copy Number Variants in iPSCs 14. Human induced pluripotent stem cells for modeling Brugada syndrome 15. iPSCs for Erythromycin Arrhythmogenicity Testing 16. Therapeutic Potential of Induced Pluripotent Stem Cell derived Extracellular Vesicles: Quo Vadis? Terra Incognito 17. Proteomic Approach for Creation of the Protein Marker Panels to Control for Quality of Human Induced Pluripotent Stem Cells (hiPSCs) 18. Application of induced pluripotent stem cells in tissue engineering 19. Application of iPSC-derived secretome in regenerative medicine 20. iPSCs and toxicology: predictive tool for present and future 21. Rejuvenation through iPSCs and reprogramming in vivo and in vitro
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
